Correlation Between GSK Plc and Santen Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GSK Plc and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GSK Plc and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GSK plc and Santen Pharmaceutical Co, you can compare the effects of market volatilities on GSK Plc and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GSK Plc with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of GSK Plc and Santen Pharmaceutical.

Diversification Opportunities for GSK Plc and Santen Pharmaceutical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GSK and Santen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding GSK plc and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and GSK Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GSK plc are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of GSK Plc i.e., GSK Plc and Santen Pharmaceutical go up and down completely randomly.

Pair Corralation between GSK Plc and Santen Pharmaceutical

Assuming the 90 days horizon GSK Plc is expected to generate 2.91 times less return on investment than Santen Pharmaceutical. But when comparing it to its historical volatility, GSK plc is 1.19 times less risky than Santen Pharmaceutical. It trades about 0.02 of its potential returns per unit of risk. Santen Pharmaceutical Co is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  765.00  in Santen Pharmaceutical Co on August 24, 2024 and sell it today you would earn a total of  250.00  from holding Santen Pharmaceutical Co or generate 32.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy72.11%
ValuesDaily Returns

GSK plc  vs.  Santen Pharmaceutical Co

 Performance 
       Timeline  
GSK plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GSK plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Santen Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Santen Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

GSK Plc and Santen Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GSK Plc and Santen Pharmaceutical

The main advantage of trading using opposite GSK Plc and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GSK Plc position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.
The idea behind GSK plc and Santen Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device